Literature DB >> 10378026

Vertical transmission of HIV: parameters which might affect infection of placental trophoblasts by HIV-1: a review. Biomed Group on the Study of in Utero Transmission of HIV 1.

M Moussa1, B Mognetti, S Dubanchet, E Menu, P Roques, G Gras, D Dormont, F Barre-Sinoussi, G Chaouat.   

Abstract

PROBLEM: To understand the mechanisms preventing and/or facilitating maternofetal transmission of human immunodeficiency virus (HIV)-1 across the placenta during pregnancy. METHODS OF STUDY: Current experimental data were reviewed. RESULTS AND
CONCLUSIONS: The data about the production of cytokines by placental cells and explants, taken together with information indicating selective passage of certain HIV-1 variants across the placental trophoblast, suggest an intricate regulatory network operating at the fetomaternal interface. The data show a differential differentiation of early and late trophoblasts, as far as HIV entry routes are concerned. We believe this explains the relative predominance of the early infection window, as far as in utero infection is concerned. Whether such a differentiation state can be transiently induced on term placental trophoblasts by several differentiation agents, including cytokines, is being investigated. Whatever the results may be, it is obvious that infection of placental cells is an excellent model of passage infection by HIV of/through a mucosal barrier.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378026     DOI: 10.1111/j.1600-0897.1999.tb00444.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  8 in total

1.  Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy.

Authors:  Maria-Teresa Gervasi; Roberto Romero; Gabriella Bracalente; Tinnakorn Chaiworapongsa; Offer Erez; Zhong Dong; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Gil Mor; Luisa Barzon; Elisa Franchin; Valentina Militello; Giorgio Palù
Journal:  J Matern Fetal Neonatal Med       Date:  2012-05-30

2.  Differential expression of RDC1/CXCR7 in the human placenta.

Authors:  Vishwas Tripathi; Romsha Verma; Amit Dinda; Neena Malhotra; Jagdeep Kaur; Kalpana Luthra
Journal:  J Clin Immunol       Date:  2008-10-28       Impact factor: 8.317

3.  HLA-G 14 bp deletion/insertion polymorphism and mother-to-child transmission of HIV.

Authors:  L Segat; L Zupin; H-Y Kim; E Catamo; D M Thea; C Kankasa; G M Aldrovandi; L Kuhn; S Crovella
Journal:  Tissue Antigens       Date:  2014-03

4.  Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France.

Authors:  A Faye; S Pornprasert; J-Y Mary; G Dolcini; M Derrien; F Barré-Sinoussi; G Chaouat; E Menu
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

5.  Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta.

Authors:  Guillermina Laura Dolcini; María Elisa Solana; Guadalupe Andreani; Ana María Celentano; Laura María Parodi; Ana María Donato; Natalia Elissondo; Stella Maris González Cappa; Luis David Giavedoni; Liliana Martínez Peralta
Journal:  Retrovirology       Date:  2008-07-01       Impact factor: 4.602

Review 6.  Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission.

Authors:  Ronaldo Celerino da Silva; Ludovica Segat; Sergio Crovella
Journal:  Hum Immunol       Date:  2011-01-26       Impact factor: 2.850

7.  Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women.

Authors:  Anfumbom Kfutwah; Jean Yves Mary; Brigitte Lemen; Robert Leke; Dominique Rousset; Françoise Barré-Sinoussi; Eric Nerrienet; Elisabeth Menu; Ahidjo Ayouba
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

Review 8.  Cellular and molecular mechanisms of viral infection in the human placenta.

Authors:  Moises León-Juárez; Macario Martínez-Castillo; Luis Didier González-García; Addy Cecilia Helguera-Repetto; Verónica Zaga-Clavellina; Julio García-Cordero; Arturo Flores-Pliego; Alma Herrera-Salazar; Edgar Ricardo Vázquez-Martínez; Enrique Reyes-Muñoz
Journal:  Pathog Dis       Date:  2017-09-29       Impact factor: 3.166

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.